.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Merck
Teva
Colorcon
Johnson and Johnson
QuintilesIMS
Fuji
Federal Trade Commission
Citi
UBS

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018613

« Back to Dashboard
NDA 018613 describes OVIDE, which is a drug marketed by Taro Pharm and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the OVIDE profile page.

The generic ingredient in OVIDE is malathion. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the malathion profile page.

Summary for 018613

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:2
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for NDA: 018613

Mechanism of ActionCholinesterase Inhibitors

Medical Subject Heading (MeSH) Categories for 018613

Suppliers and Packaging for NDA: 018613

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OVIDE
malathion
LOTION;TOPICAL 018613 NDA TARO PHARMACEUTICALS USA, INC. 51672-5276 51672-5276-4 1 BOTTLE in 1 CARTON (51672-5276-4) > 59 mL in 1 BOTTLE
OVIDE
malathion
LOTION;TOPICAL 018613 NDA TARO PHARMACEUTICALS U.S.A., INC. 51672-5277 51672-5277-4 1 BOTTLE in 1 CARTON (51672-5277-4) > 59 mL in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength0.5%
Approval Date:Aug 2, 1982TE:ATRLD:Yes
Patent:► SubscribePatent Expiration:Feb 1, 2027Product Flag?YSubstance Flag?YDelist Request?
Patented Use:TREATMENT OF PATIENTS INFECTED WITH PEDICULUS HUMANUS CAPITIS (HEAD LICE AND THEIR OVA) OF THE SCALP HAIR
Patent:► SubscribePatent Expiration:Aug 14, 2026Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Julphar
Covington
QuintilesIMS
US Department of Justice
Farmers Insurance
Daiichi Sankyo
Citi
Fuji
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot